TD Asset Management’s PTC Therapeutics PTCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-46,874
Closed -$1.29M 1424
2023
Q4
$1.29M Sell
46,874
-12,200
-21% -$336K ﹤0.01% 1123
2023
Q3
$1.32M Sell
59,074
-7,563
-11% -$169K ﹤0.01% 1074
2023
Q2
$2.71M Buy
66,637
+26,386
+66% +$1.07M ﹤0.01% 884
2023
Q1
$1.95M Buy
40,251
+21,354
+113% +$1.03M ﹤0.01% 994
2022
Q4
$721K Sell
18,897
-13,316
-41% -$508K ﹤0.01% 1206
2022
Q3
$1.62M Buy
32,213
+900
+3% +$45.3K ﹤0.01% 1071
2022
Q2
$1.25M Sell
31,313
-4,801
-13% -$192K ﹤0.01% 1137
2022
Q1
$1.35M Sell
36,114
-10,320
-22% -$385K ﹤0.01% 1182
2021
Q4
$1.85M Buy
46,434
+4,518
+11% +$180K ﹤0.01% 1150
2021
Q3
$1.56M Hold
41,916
﹤0.01% 1150
2021
Q2
$1.61M Sell
41,916
-1,889
-4% -$72.4K ﹤0.01% 1157
2021
Q1
$2.07M Buy
43,805
+2,000
+5% +$94.7K ﹤0.01% 1093
2020
Q4
$2.55M Buy
41,805
+2,307
+6% +$141K ﹤0.01% 969
2020
Q3
$1.85M Sell
39,498
-1,900
-5% -$88.8K ﹤0.01% 929
2020
Q2
$2.1M Buy
41,398
+11,600
+39% +$589K ﹤0.01% 868
2020
Q1
$1.33M Sell
29,798
-49,833
-63% -$2.22M ﹤0.01% 927
2019
Q4
$3.83M Sell
79,631
-3,025
-4% -$145K 0.01% 775
2019
Q3
$2.8M Buy
82,656
+625
+0.8% +$21.1K ﹤0.01% 830
2019
Q2
$3.69M Buy
82,031
+3,000
+4% +$135K 0.01% 764
2019
Q1
$2.98M Buy
79,031
+12,600
+19% +$474K ﹤0.01% 824
2018
Q4
$2.28M Buy
66,431
+10,000
+18% +$343K ﹤0.01% 883
2018
Q3
$2.65M Buy
56,431
+41,600
+280% +$1.96M ﹤0.01% 928
2018
Q2
$500K Buy
+14,831
New +$500K ﹤0.01% 1262